SlideShare une entreprise Scribd logo
1  sur  88
1
CNS STIMULANTS
&
COGNITIVE ENHANCERS
2
CNS STIMULANTS
The CNS stimulants mostly produce a generalized
action which may, at high doses, result in
convulsions.
They are drugs which increase the muscular
(motor) and the mental (sensory) activities.
Their effects vary from the increase in the
alertness and wakefulness (as with caffeine) to
the production of convulsion ( as with
strychnine) and sometimes lead to death in over
dose.
CLASSIFICATION
1. Convulsants: Strychnine,Picrotoxin,Bicuculline,
Pentylenetetrazol (PTZ).
2. Analeptics(respiratory stimulants): Doxapram
3. Psychomotor stimulants: Amphetamines,
MDMA,DEXAMPHETAMINE,Methylphenidate
Atomoxetine,Modafinil,Armodafinil,Sibutramine
Pemoline, Cocaine,
Caffeine.
 Many other drugs are capable of causing CNS
stimulation as side effect or at high doses.
CONVULSANTS
CONVULSANTS
1. Strychnine: It is an alkaloid from the seeds of
Strychnos nux-vomica,and a potent convulsant.
Example Strychnine (30mg)
Site of
action Spinal cord.(stimulant)
MOA
Block the postsynaptic inhibitory
response to glycine by blocking glycine
receptors. Glycine is the main inhibitory
transmitter acting on motor neurons.
End point
Tonic convulsion.( slow IV diazepam/clonazepam
Opisthotonus Also seen in;
•Cerebral
palsy
•Traumatic
•Brain injury
-tetanus
Picrotoxin :
Obtained from ‘fish berries’ of East Indies
Anamirta cocculus. It is a potent convulsant—
convulsions are clonic, spontaneous and
asymmetrical. The convulsions are accompanied
by vomiting, respiratory and vasomotor
stimulation.
Examples Picrotoxin (20mg)
Site of
action
Medulla oblongata.
MOA
1.It inhibits the presynaptic
inhibition→decrease GABA.
2.Non-competitive GABAA
receptors blocker which is a
chloride channel blocker.
End point
Clonic convulsions
hyperpolarisation-excitation.
Treatment Symptomatic (diazepam)
BICUCULLINE :
• This synthetic convulsant has picrotoxin
like actions.
• It is a competitive GABA-A receptor (intrinsic
Cl¯ channel receptor) antagonist.
• NO CLINICAL USE
• It is only a research tool.
Dicentra cucularia
PENTYLENETETRAZOL (PTZ)
laptazol, metrazol
It is a powerful CNS stimulant
Low doses cause excitation, larger doses produce
Convulsions
Antagonism of PTZ induced convulsions is an
established method of testing anticonvulsant
drugs in laboratory animals
DOC :- diazepam/clonazepam.
ANALEPTICS
ANALEPTICS (Respiratory stimulants)
These are drugs which stimulate respiration and can
have resuscitative value in coma or fainting.
Mechanical support to respiration and other
measures to improve circulation are more effective
and safe.
Low doses they are selectively act on resp center
Inc depth of breathing by acting on resp center in
medulla
Situations in which analeptics may be employed
are:
(a) As an expedient measure in hypnotic drug
poisoning untill mechanical ventilation is
introduced.
(b) Suffocation on drowning, acute respiratory
insufficiency.
(c) Apnoea in premature infant.
(d) Failure to ventilate spontaneously after
general anaesthesia.
Doxapram:
It acts by promoting excitation of central
neurons.
At low doses it is more selective for the
respiratory centre.
Respiration is stimulated through carotid and
aortic body chemoreceptors.
Continuous i.v. infusion of doxapram may abolish
episodes of apnoea in premature infant not
responding to theophylline.
Uses :
 Post-anaesthetic resp. depression
 COPD i.e. hypoxemic, hypercapnic res.failure.
 Apnoea in premature infants
Dose- 2-5mg/min(max 4mg/kg) slow i.v infusion.
Contraindications:
 Resp.fail due to neurological & muscular
diseases.
 Epilepsy
Side effect:
 Restlessness, Tachycardia
 High doses: convulsions & arrhythmias
PSYCHO
STIMULANTS
PSYCHOMOTOR STIMULANTS
Amphetamine group:
 Amphetamine
 Dexamphetamine
 Methamphetamine
 Methylenedioxy Methampheta(MDMA)
 Methylphenedate
 Fenfluramine
Non-Amphetamine group
 Modafinil
 Atomoxetine
 Sibutramine
 Pemoline
Cocaine
Methylxanthines:
 Caffeine
 Theophylline
 Theobromine
26
 PSYCHOMOTOR STIMULANT.
 DERIVATIVES:
DEXAMPHETAMINE,METHAMPHETAMINE,MDMA.
 EFFECTS:
MOTOR ACTIVITY
EUPHORIA
ANOREXIA
EXCITEMENT
REDUCED FATIGUE.
STEREOTYPED AND PSYCHOTIC BEHAVIOUR.
INCREASE IN SEXUAL DRIVE.
OTHER NAMES: SPEEED, BILLY WIZZ, POORMANS COCAINE
AMPHETAMINE
PSYCHOMOTOR STIMULANTS
Amphetamine & Non- Amphetamine:
MOA:
 Drug enter N endings by active transport
 Displace DA(also NE) from vesicles by altering pH
 ↑DA conc. In synaptic cleft
 Also inhibits MOA-B, ↓DA metabolism & DA
 Release to synaptic cleft by reverse transport
28
PERIPHERAL EFFECTS
 ↑ BP,inhibition of GI motility
 Fatigue both physical & mental reduced.
 Amphetamine psychosis on repeated use-
hallucinations.(NO VISUAL)
AGGRESIVENESS ON OVER DOSAGE.
PK:
 Well absorbed orally
 Freely penetrates BBB
 Unmetabolised drug excreted in urine
USES
ADHD with minimal brain dysfunction:
 Characterised by-
 Hyperactivity
 Inability to concentrate
 Impulsive behavior
Dexamphetamine,
Methylphenedate,
Atomoxetine quite effective.
Narcolepsy: Characterised by-
 Sleep attacks during day time
 VIVID Night mares in awakening state
CATAPLEXY (loss of muscle tone).
Methylphenedate is still used
Modafinil- used successfully.
devoid of abuse liability
APPETITE SUPPRESSION
 Fenfluramine, dexfenfluramine used earlier to
treat obesity
Discouraged due to:-
 Tolerance
 Insomnia, Pul.HTN, Abuse potential.
Sibutramine new drug used now
 Blocks neuronal uptake of mainly NE & 5HT
(also dopamine) at hypothalamic site that
regulates food intake.
Use:
 Severe obesity with risk factors like DM.
Adverse effects:
 Dry mouth
 Headache
 Insomnia
 Constipation
 ↑in HR & BP
 CI in CVS diseases, withdrawn from market
ADVERSE EFFECTS
 Tolerance
 Psychic dependence, rarely physical.
Amphetamine overdose:
 Euphoria, dizziness, tremors, HTN
Irritability, anorexia, insomnia
 Higher doses- convulsions, psychotic
manifestations, arrhythmias, coma
• Aamphetamine toxicity treated with DIAZEPAM (SLOW IV)
• FOR PSYCHOTIC AGITATION – HALOPERIDOL
• GASTRIC LAVAGE
 Acidification of urine by administering AMMONIUM CHLORIDE &
ASCORBIC ACID. This increase elimination of amphetamine in urine.
 Anti-hypertensive drugs like – LABETOLOL
 For ARRYTHMIAS - ESMOLOL
Treatment typically requires more than one year of Intense intervention
consisting of drug abstinence,cognitive, emotional and motivational
rehabilitation.
Treatment Of Acute Poisoning
38
 also called ECTASY. (love drug)
INDUCES THE RELEASE OF NE,DA
Induces heat stroke like condition-
rhabdomyolysis & renal failure
Methamphetamine = meth
75mg- psychotomimetic effects
150 mg-LSD like effects
300mg- amphetamine like
 SE: tachycardia, HTN, arrhythmias
aphrodisiac, euphoriant
MDMA=methylenedioxy methamphetamine
42
History of Cocaine
SIGMUND FRAUD USED COCAINE FOR
TREAT DEPRESSION.
ALBERT NEIMANN
from coca leaves.
43
What is it?
Pure cocaine was first isolated from the leaves of the coca
bush in 1860.
Contained in small amounts in the leaves of
ERYTHROXYLUM (coca) bush
Researchers soon discovered that cocaine numbs whatever
tissue it touches.
This lead to it’s use as a local anesthetic.
44
Where does it come
Coca leaves grow on the slopes of the Andes
Mountains.
For at least 4,500 years, people in Peru & Bolivia have
chewed the coca leaves to lessen hunger & fatigue.
Most of the world’s supply of coca is grown & refined
into cocaine in Colombia.
HIGHEST ABUSE LIABILITY.
45
How is it used
SNIFFED (15 – 30 min)
46
SMOKED
(5-10 min)
INJECTED
3min
Cocaine
Pharmacodynamics
Indirect Agonist for
DA (high affinity)
NE (high affinity)
5-HT (modest affinity)
47
• Mechanism:
– Blocks monoamine
reuptake
Short-term effects
Dilated pupils
Increased body temperature, Blood pressure & heart rate
Insomnia
Loss of appetite
Increased energy
Reduced fatigue
Mental clarity
Talkativeness
48
Long-term effects
Paranoia
Depression
Ulcers in the membranes of the nose
Dulled senses of taste & smell
Weight loss, poor health & sexual dysfunction
Loss of social & financial supports
Holes in bony separation between nostrils in nose
49
50
COCAINE+ HEROIN
Concurrent or substitute use
Multiple drug use (nicotine, alcohol, heroin,
amphetamines, hallucinogens).
Cocaine + heroin => “speed ball”
51
PHARMACOTHERAPIES
Treatment of withdrawal:
Alpha-blockers
Chlorpromazine: DA antagonist (also blocks alpha receptors)
Haloperidol (antipsychotic – 50x more potent than
chlorpromazine).
Alprazolam (Xanax - benzodiazepine) for panic attacks.
Antidepressants (fluoxetine or desipramine).
Diazepam (Valium) for seizures
AMANTIDINE for withdrawl effects of cocaine.
52
53
 Cocaine is known to have a number of effects
during pregnancy.
 elevated risk of placental abruption
 Due to its vasoconstrictive and hypertensive
effects, they are also at risk for haemorrhagic
stroke and myocardial infarction.
 Cocaine is also teratogenic it can cause birth
defects and foetal malformations.
 cocaine babies
COCAINE IN PREGNANCY
METHYLXANTHINES
 Only caffeine if used as CNS stimulant
PK:
 Oral- rapid but irregular absorption
 PPB:<50%
 Distributed all over the body
 Metabolism: in liver by demethylation & oxid.
 Metabolites excreted in urine
 T1/2: 3-6hrs
AE:
 Gastric irritation, Nause, Vomiting.
 Nervousness, insomnia, agitation
 Muscule twitch, rigidity
 ↑body temp, delirium, convulsions
 Tachy, extra systoles at high doses
Uses:
 In Analgesic mixture for headache
 Migraine
 Apnoea in premature infants
PSYCHOTOMIMETIC
58
 LYSEGIC ACID DIETHYLAMIDE
 MESCALINE
 PHENCYCLIDINE
 CANNABINOIDS
 Molecular target- 5-HT2AR – Gq receptor
 Hallucinogens
LYSERGIC ACID DIETHYLAMIDE
 Derived from cereal fungus ergot
 Hofmann synthesized & experimented on himself.
 Act as agonist at 5HT2 receptors.
suppress electrical activity in sertoninergic raphe
 Excitation threshold of retina ↓- visual
hallucinations, hyper arousal state
 Experiences may be bad or good trip.
psychedelic effects with 1μg/kg.
trips lasting for 6-12 hours.
experience flashbacks at any time.
Mescaline
Mescaline – A hallucinogen obtained from a
small spineless cactus Peyote.
From earliest recorded time, peyote has been used by natives in
northwestern Mexico and the southwestern United States as a
part of traditional religious rites.
The drug is usually taken orally, without chewing, although it can
still be smoked, or even injected.
It’s chemical structure is close to that of an amphetamine
(stimulant).
61
PSILOCYBIN MUSHROOMS
How are they taken?
Eaten raw
Cooked in food
Brewed in tea
Dried and ingested
Street names:
Magic mushrooms
“Shrooms”
How long does a trip last?
5-6 hours
62
Psilocybin Mushrooms Effects
Nausea
Dilated pupils
Tightness in the neck
• Induce sensory hallucinations
• Hear things that are not real
Effects caused by shrooms begin about 30 min.
after consumption and last nearly 5 hours.
During this period, laughing is somewhat uncontrollable
and visual hallucinations caused by organic objects are
typical.
Psilocybin acts by affinity to serotonin 5-HT receptors.
63
CANNABINOIDS
 Cannabis Sativa (Hemp)
Cannabis indicia
 GATEWAY DRUG
Psychoactive agent = ∆9 Tetrahydocannabinol (THC)
Found in all parts of the plant, but concentrated in the
sticky resin secreted from the flowing tops of ♀ plants.
WORLDS MOST POPULAR DRUG OF ABUSE
 The herb was called GANJIKA in Sanskrit
65
HASH OIL:
It obtained by extracting THC from Hashish or
Marijuana in oil.
 Clear pale yellow / green
to brown black colour.
 THC concentration 15-30%.
GANJA: Buds and flowering top of
female plant.
BHANG: Cut and dried large
leaves & stem of plants. 6
66
67
MARIJUANA
- Dried and crumbled leaves, small
stems, flowing tops of the plant
- Usually smoked in joints,
pipes, bongs,
- also called grass,
pot,weed,reefer.
- THC content varies…
SINSEMILLA:
pollination prevented (↑ potency)
The Gang Bong: The 4 barrel brain blaster!
MECHANISM OF
ACTION
68
Common Routes- CANNABINOIDS
69
 Smoking
 Oral ingestion
 Cannabis tea
 Cannabis+alcohol = green dragon
PHARMACOLOGY OF CANNABIS
 11- hydroxyl ∆9-THC.(active form)
 Typical Joint contains approximately 0.5 – 1g of cannabis
- If THC content = 4%... joint with 1g of cannabis contains 40 mg of
THC
 Burning marijuana results in vaporisation of THC→ absorption
into the lungs
 Only about 20% of original THC is absorbed:
Breathing isn’t optimal –
can be increased by breath holding
Increased high with 15 s breath hold vs. 7 s
70
ACTIONS - CANNABIS
71
DURING SEDATIVE PHASE: IMPAIRED CONCENTRATION
LSD LIKE EFFECTS
IMPAIRED SHORT TERM MEMORY
-
DURING STIMULATORY PHASE:
EUPHORIA
TALKTIVENSS, APPETITE
FEELING OF WELL-BEING
MOOD TRIPS WILL BE SEEN.
PERIPHERAL EFFECTS: TACHYCARDIA
BLOODSHOT EYES
IOP
BRONCHODILATATION
AMOTIVATION SYNDROME.
RUNNING AMOK CHRONIC POISONING
MOA, USES
 Two types CB 1& 2 receptors
 CB1 in brain CB2 in periphery
 Anandamide-endogenous ligand CB1.
 Dronabinol, Nabilone- synt.analogues of THC
 Use: CB1 Agonists- ↑appetite in AIDSpts.
 Dronabinol-antiemetic in cancerchemo.
 Rimonabant : CB1 antagonist, used for obesity,
dose-20mg OD before Breakfast
 Smoking cessation
COGNITIVE
ENHANCERS
COGNITION ENHANCERS
Cognition is "the mental action or process of
acquiring knowledge and understanding through
thought, experience, and the senses.“
It encompasses processes such
as knowledge, attention, memory and working
memory, judgment and evaluation, reasoning an
d "computation", problem solving and decision
making, comprehension and production
of language,
COGNITION ENHANCERS
Indications:
 AD, multi infarct dementia
 Mild cognitive impairment
 learning defects, ADHD in children
 CVA, Stroke,TIA
 Organic psychosyndromes
 Sequale of head injury
 ECT, brain surgery
MECHANISMS
 ↑ global/regional blood flow(CBF)
 Direct support of neuronal metabolism
 Enhancement of neurotransmission
 Improvement of discrete cerebral functions
(memory)
ALZHEIMERS DISEASE
 Main pathological features:
 Amyloid plaque
 Neurofibrillary tangles
 Marked ↓ in choline acetyltransferase & loss
of cholinergic neurons in brain.
CHOLINERGIC ACTIVATORS
 ACEs that cross BBB are preferred.
Tacrine:
 Longer acting, reversible ACE
 Palliative for mild to moderate AD
 Orally active
 Improves memory, cognition, well being
 Facilitates Ach release
 AE: hepatotoxicity
DONEPEZIL, RIVASTIGMINE & GALANTAMINE
 Newer reversible Anti cholinesterase
 Better penetration in to CNS(lipid soluble)
 Better tolerated & less toxic than tacrine
 Clinical results modest & temporary
 Donepezil: 5mg OD orally evening ↑ max
10mg after 4 wks
 Rivastigmine:1.5 mg orally BD ↑ to 3mg BD
after 2 wks upto max 6mg/BD.
 Galantamine:4mg BD orally ↑to 8mg BD after
2 wks
 Transdermal Rivastigmine patch –applied
every 24hrs
 SE:diarrhoe, N, V, ↑urination
Acetyl-L-carnitine:
 Structural analogue of Ach
 ↓ signs & symptoms of dementia in AD
 ↑ cholinergic transmission
 Also have antioxidant properties, slows
progression ofAD
MEMANTINE
 Excitotoxicity due to enhanced Glutamate
transmission via NMDA recp.
 Dose:5mg OD slowly ↑ to 10-20mg/day
 Non-comp. antagonist of NMDA recp.
 Better tolerated, less toxic.
Miscellaneous :
 Nootropics- piracetam, aniracetam
 High doses of vit E(1000 IU B.D)
 Antioxidants-vit C, A, Zn, Se, bioflavonoids or
spirulina ↓ progression even in middle stage
AD.
84
PIRACETAM
MOA:-
↑ ACh activity in the brain
↑ glutamate activity via AMPA and NMDA receptors
~ improve membrane permeability of neurons→ enhances overall
neuronal function.
USE :-
Cognitive impairement & Dementia in elderly, ADHD.
DOSE:-
0.8-1 gm TDS, Oral
1-3 gm, i.m, 6th hrly.
85
Natural Nootropics:-
Bacopa monnieri (Brahmi):
• Enhancement of PK activity, protein synthesis in
hippocampus
• Natural antioxidant & DNA damage preventing agent
•Anti stress property
• It enhances memory and intellect.
86ASHWAGANDHA:
 Indian GINSENG
 Anti oxidant properties
 Neuronal regeneration : Which helps in
Neuro degenerative disorders.
 Extract inhibits AchE enzyme.
87
Ginkgo biloba:
 Neuro protective effects
Antioxidant, Anti apoptotic, Anti amyloidogenic properties
Used in Alzhiemer’s disease , other cognitive disorders.
Panax Ginseng (king herb):
 Chinese traditional medicine
Antioxidant property
Release of neurotransmitters in the brain
THANK YOU

Contenu connexe

Tendances

Tendances (20)

Sedatives and hypnotics
Sedatives and hypnotics Sedatives and hypnotics
Sedatives and hypnotics
 
Pharmacology of dopamine
Pharmacology of dopaminePharmacology of dopamine
Pharmacology of dopamine
 
Antidepressants -pharmacology
Antidepressants -pharmacologyAntidepressants -pharmacology
Antidepressants -pharmacology
 
Cns stimulant final ppt july 2021
Cns stimulant final ppt  july 2021Cns stimulant final ppt  july 2021
Cns stimulant final ppt july 2021
 
CNS stimulants - Parmacology
CNS stimulants - ParmacologyCNS stimulants - Parmacology
CNS stimulants - Parmacology
 
Antiparkinsonian drugs
Antiparkinsonian drugsAntiparkinsonian drugs
Antiparkinsonian drugs
 
Parasympathomimetics (Cholinergic drugs)
Parasympathomimetics (Cholinergic drugs)Parasympathomimetics (Cholinergic drugs)
Parasympathomimetics (Cholinergic drugs)
 
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASE
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASEANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASE
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASE
 
Centrally acting smr
Centrally acting smrCentrally acting smr
Centrally acting smr
 
ALCOHOL & DISULFIRAM - PHARMACOLOGY
ALCOHOL & DISULFIRAM - PHARMACOLOGYALCOHOL & DISULFIRAM - PHARMACOLOGY
ALCOHOL & DISULFIRAM - PHARMACOLOGY
 
Anti psychotic drugs
Anti psychotic drugsAnti psychotic drugs
Anti psychotic drugs
 
Drug therapy of depression
Drug therapy of depression Drug therapy of depression
Drug therapy of depression
 
Cns stimulant by yogesh sangle
Cns stimulant by yogesh sangleCns stimulant by yogesh sangle
Cns stimulant by yogesh sangle
 
Antipsychotic drug
Antipsychotic drug Antipsychotic drug
Antipsychotic drug
 
Drug treatment of alzheimers disease
Drug treatment of alzheimers diseaseDrug treatment of alzheimers disease
Drug treatment of alzheimers disease
 
parasympathomimetics drugs
  parasympathomimetics drugs  parasympathomimetics drugs
parasympathomimetics drugs
 
Parasympathomimetics and parasympatholytics Pharmacology.
Parasympathomimetics and parasympatholytics Pharmacology. Parasympathomimetics and parasympatholytics Pharmacology.
Parasympathomimetics and parasympatholytics Pharmacology.
 
Sedative and hypnotics
Sedative and hypnoticsSedative and hypnotics
Sedative and hypnotics
 
Antidepressant drugs
Antidepressant drugsAntidepressant drugs
Antidepressant drugs
 
Sympathomimetics
SympathomimeticsSympathomimetics
Sympathomimetics
 

Similaire à CNS stimulants and cognitive enhancers

CNS STIMULANTS & COGNITIVE ENHANCERS
CNS STIMULANTS&COGNITIVE ENHANCERSCNS STIMULANTS&COGNITIVE ENHANCERS
CNS STIMULANTS & COGNITIVE ENHANCERS
GHSPL
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
raj kumar
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
raj kumar
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
raj kumar
 
8QuyYhigEyF50OSLZMog.pdf
8QuyYhigEyF50OSLZMog.pdf8QuyYhigEyF50OSLZMog.pdf
8QuyYhigEyF50OSLZMog.pdf
Imtiyaz60
 
Disorders of the reward system
Disorders of the reward systemDisorders of the reward system
Disorders of the reward system
Adonis Sfera, MD
 

Similaire à CNS stimulants and cognitive enhancers (20)

CNS STIMULANTS & COGNITIVE ENHANCERS
CNS STIMULANTS&COGNITIVE ENHANCERSCNS STIMULANTS&COGNITIVE ENHANCERS
CNS STIMULANTS & COGNITIVE ENHANCERS
 
cnsstimulants & cognitive enhancers.pptx
cnsstimulants & cognitive enhancers.pptxcnsstimulants & cognitive enhancers.pptx
cnsstimulants & cognitive enhancers.pptx
 
CNS stimulants by Nilesh sharma
CNS stimulants by Nilesh sharmaCNS stimulants by Nilesh sharma
CNS stimulants by Nilesh sharma
 
2.CNS Stimulants.pptx
2.CNS Stimulants.pptx2.CNS Stimulants.pptx
2.CNS Stimulants.pptx
 
Central Nervous System Stimulants presentation
Central Nervous System Stimulants presentationCentral Nervous System Stimulants presentation
Central Nervous System Stimulants presentation
 
1633799628 235553d83656729aefdf4016d0fe5a28
1633799628 235553d83656729aefdf4016d0fe5a281633799628 235553d83656729aefdf4016d0fe5a28
1633799628 235553d83656729aefdf4016d0fe5a28
 
CNS stimulants
CNS stimulantsCNS stimulants
CNS stimulants
 
Cnsstimulants.pptx
Cnsstimulants.pptxCnsstimulants.pptx
Cnsstimulants.pptx
 
IVMS-CNS Pharmacology Intro to Drugs of Abuse III-Stimulants
IVMS-CNS Pharmacology Intro to Drugs of Abuse III-StimulantsIVMS-CNS Pharmacology Intro to Drugs of Abuse III-Stimulants
IVMS-CNS Pharmacology Intro to Drugs of Abuse III-Stimulants
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 
stimulants
stimulantsstimulants
stimulants
 
8QuyYhigEyF50OSLZMog.pdf
8QuyYhigEyF50OSLZMog.pdf8QuyYhigEyF50OSLZMog.pdf
8QuyYhigEyF50OSLZMog.pdf
 
Drug used in Parkinson,Alzheimer and CNS stimulants
Drug used in Parkinson,Alzheimer and CNS stimulantsDrug used in Parkinson,Alzheimer and CNS stimulants
Drug used in Parkinson,Alzheimer and CNS stimulants
 
cns stimulants and drug abuse.pdf
cns stimulants and drug abuse.pdfcns stimulants and drug abuse.pdf
cns stimulants and drug abuse.pdf
 
Premedication
PremedicationPremedication
Premedication
 
Respiratory stimulants
Respiratory stimulants Respiratory stimulants
Respiratory stimulants
 
Disorders of the reward system
Disorders of the reward systemDisorders of the reward system
Disorders of the reward system
 
3 general anethesia
3 general anethesia3 general anethesia
3 general anethesia
 

Plus de Mahi Yeruva (9)

Estrogen
EstrogenEstrogen
Estrogen
 
CARDIOGENIC SHOCK
CARDIOGENIC SHOCKCARDIOGENIC SHOCK
CARDIOGENIC SHOCK
 
Antianxietydrugs 160402025443
Antianxietydrugs 160402025443Antianxietydrugs 160402025443
Antianxietydrugs 160402025443
 
Mahi anti depressants
Mahi anti depressantsMahi anti depressants
Mahi anti depressants
 
Anti parkinsonism drugs by dr.mahi yeruva
Anti parkinsonism drugs by dr.mahi yeruvaAnti parkinsonism drugs by dr.mahi yeruva
Anti parkinsonism drugs by dr.mahi yeruva
 
SKELETAL MUSCLE RELAXANTS
SKELETAL MUSCLE RELAXANTSSKELETAL MUSCLE RELAXANTS
SKELETAL MUSCLE RELAXANTS
 
Pharmacogenetics by dr.mahi
Pharmacogenetics by dr.mahiPharmacogenetics by dr.mahi
Pharmacogenetics by dr.mahi
 
Drug dependence & Drug Abuse
Drug dependence & Drug AbuseDrug dependence & Drug Abuse
Drug dependence & Drug Abuse
 
Receptor seminar by Dr.Mahi Yeruva
Receptor seminar by Dr.Mahi YeruvaReceptor seminar by Dr.Mahi Yeruva
Receptor seminar by Dr.Mahi Yeruva
 

Dernier

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
kauryashika82
 

Dernier (20)

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 

CNS stimulants and cognitive enhancers

  • 2. 2
  • 3. CNS STIMULANTS The CNS stimulants mostly produce a generalized action which may, at high doses, result in convulsions. They are drugs which increase the muscular (motor) and the mental (sensory) activities. Their effects vary from the increase in the alertness and wakefulness (as with caffeine) to the production of convulsion ( as with strychnine) and sometimes lead to death in over dose.
  • 4.
  • 5. CLASSIFICATION 1. Convulsants: Strychnine,Picrotoxin,Bicuculline, Pentylenetetrazol (PTZ). 2. Analeptics(respiratory stimulants): Doxapram 3. Psychomotor stimulants: Amphetamines, MDMA,DEXAMPHETAMINE,Methylphenidate Atomoxetine,Modafinil,Armodafinil,Sibutramine Pemoline, Cocaine, Caffeine.  Many other drugs are capable of causing CNS stimulation as side effect or at high doses.
  • 7. CONVULSANTS 1. Strychnine: It is an alkaloid from the seeds of Strychnos nux-vomica,and a potent convulsant. Example Strychnine (30mg) Site of action Spinal cord.(stimulant) MOA Block the postsynaptic inhibitory response to glycine by blocking glycine receptors. Glycine is the main inhibitory transmitter acting on motor neurons. End point Tonic convulsion.( slow IV diazepam/clonazepam
  • 8. Opisthotonus Also seen in; •Cerebral palsy •Traumatic •Brain injury -tetanus
  • 9.
  • 10.
  • 11. Picrotoxin : Obtained from ‘fish berries’ of East Indies Anamirta cocculus. It is a potent convulsant— convulsions are clonic, spontaneous and asymmetrical. The convulsions are accompanied by vomiting, respiratory and vasomotor stimulation.
  • 12. Examples Picrotoxin (20mg) Site of action Medulla oblongata. MOA 1.It inhibits the presynaptic inhibition→decrease GABA. 2.Non-competitive GABAA receptors blocker which is a chloride channel blocker. End point Clonic convulsions hyperpolarisation-excitation. Treatment Symptomatic (diazepam)
  • 13.
  • 14. BICUCULLINE : • This synthetic convulsant has picrotoxin like actions. • It is a competitive GABA-A receptor (intrinsic Cl¯ channel receptor) antagonist. • NO CLINICAL USE • It is only a research tool.
  • 16. PENTYLENETETRAZOL (PTZ) laptazol, metrazol It is a powerful CNS stimulant Low doses cause excitation, larger doses produce Convulsions Antagonism of PTZ induced convulsions is an established method of testing anticonvulsant drugs in laboratory animals DOC :- diazepam/clonazepam.
  • 18. ANALEPTICS (Respiratory stimulants) These are drugs which stimulate respiration and can have resuscitative value in coma or fainting. Mechanical support to respiration and other measures to improve circulation are more effective and safe. Low doses they are selectively act on resp center Inc depth of breathing by acting on resp center in medulla
  • 19. Situations in which analeptics may be employed are: (a) As an expedient measure in hypnotic drug poisoning untill mechanical ventilation is introduced. (b) Suffocation on drowning, acute respiratory insufficiency. (c) Apnoea in premature infant. (d) Failure to ventilate spontaneously after general anaesthesia.
  • 20. Doxapram: It acts by promoting excitation of central neurons. At low doses it is more selective for the respiratory centre. Respiration is stimulated through carotid and aortic body chemoreceptors. Continuous i.v. infusion of doxapram may abolish episodes of apnoea in premature infant not responding to theophylline.
  • 21. Uses :  Post-anaesthetic resp. depression  COPD i.e. hypoxemic, hypercapnic res.failure.  Apnoea in premature infants Dose- 2-5mg/min(max 4mg/kg) slow i.v infusion. Contraindications:  Resp.fail due to neurological & muscular diseases.  Epilepsy Side effect:  Restlessness, Tachycardia  High doses: convulsions & arrhythmias
  • 22.
  • 24. PSYCHOMOTOR STIMULANTS Amphetamine group:  Amphetamine  Dexamphetamine  Methamphetamine  Methylenedioxy Methampheta(MDMA)  Methylphenedate  Fenfluramine
  • 25. Non-Amphetamine group  Modafinil  Atomoxetine  Sibutramine  Pemoline Cocaine Methylxanthines:  Caffeine  Theophylline  Theobromine
  • 26. 26  PSYCHOMOTOR STIMULANT.  DERIVATIVES: DEXAMPHETAMINE,METHAMPHETAMINE,MDMA.  EFFECTS: MOTOR ACTIVITY EUPHORIA ANOREXIA EXCITEMENT REDUCED FATIGUE. STEREOTYPED AND PSYCHOTIC BEHAVIOUR. INCREASE IN SEXUAL DRIVE. OTHER NAMES: SPEEED, BILLY WIZZ, POORMANS COCAINE AMPHETAMINE
  • 27. PSYCHOMOTOR STIMULANTS Amphetamine & Non- Amphetamine: MOA:  Drug enter N endings by active transport  Displace DA(also NE) from vesicles by altering pH  ↑DA conc. In synaptic cleft  Also inhibits MOA-B, ↓DA metabolism & DA  Release to synaptic cleft by reverse transport
  • 28. 28
  • 29. PERIPHERAL EFFECTS  ↑ BP,inhibition of GI motility  Fatigue both physical & mental reduced.  Amphetamine psychosis on repeated use- hallucinations.(NO VISUAL) AGGRESIVENESS ON OVER DOSAGE. PK:  Well absorbed orally  Freely penetrates BBB  Unmetabolised drug excreted in urine
  • 30.
  • 31. USES ADHD with minimal brain dysfunction:  Characterised by-  Hyperactivity  Inability to concentrate  Impulsive behavior Dexamphetamine, Methylphenedate, Atomoxetine quite effective.
  • 32.
  • 33. Narcolepsy: Characterised by-  Sleep attacks during day time  VIVID Night mares in awakening state CATAPLEXY (loss of muscle tone). Methylphenedate is still used Modafinil- used successfully. devoid of abuse liability
  • 34.
  • 35. APPETITE SUPPRESSION  Fenfluramine, dexfenfluramine used earlier to treat obesity Discouraged due to:-  Tolerance  Insomnia, Pul.HTN, Abuse potential. Sibutramine new drug used now  Blocks neuronal uptake of mainly NE & 5HT (also dopamine) at hypothalamic site that regulates food intake.
  • 36. Use:  Severe obesity with risk factors like DM. Adverse effects:  Dry mouth  Headache  Insomnia  Constipation  ↑in HR & BP  CI in CVS diseases, withdrawn from market
  • 37. ADVERSE EFFECTS  Tolerance  Psychic dependence, rarely physical. Amphetamine overdose:  Euphoria, dizziness, tremors, HTN Irritability, anorexia, insomnia  Higher doses- convulsions, psychotic manifestations, arrhythmias, coma
  • 38. • Aamphetamine toxicity treated with DIAZEPAM (SLOW IV) • FOR PSYCHOTIC AGITATION – HALOPERIDOL • GASTRIC LAVAGE  Acidification of urine by administering AMMONIUM CHLORIDE & ASCORBIC ACID. This increase elimination of amphetamine in urine.  Anti-hypertensive drugs like – LABETOLOL  For ARRYTHMIAS - ESMOLOL Treatment typically requires more than one year of Intense intervention consisting of drug abstinence,cognitive, emotional and motivational rehabilitation. Treatment Of Acute Poisoning 38
  • 39.  also called ECTASY. (love drug) INDUCES THE RELEASE OF NE,DA Induces heat stroke like condition- rhabdomyolysis & renal failure Methamphetamine = meth 75mg- psychotomimetic effects 150 mg-LSD like effects 300mg- amphetamine like  SE: tachycardia, HTN, arrhythmias aphrodisiac, euphoriant MDMA=methylenedioxy methamphetamine
  • 40.
  • 41.
  • 42. 42
  • 43. History of Cocaine SIGMUND FRAUD USED COCAINE FOR TREAT DEPRESSION. ALBERT NEIMANN from coca leaves. 43
  • 44. What is it? Pure cocaine was first isolated from the leaves of the coca bush in 1860. Contained in small amounts in the leaves of ERYTHROXYLUM (coca) bush Researchers soon discovered that cocaine numbs whatever tissue it touches. This lead to it’s use as a local anesthetic. 44
  • 45. Where does it come Coca leaves grow on the slopes of the Andes Mountains. For at least 4,500 years, people in Peru & Bolivia have chewed the coca leaves to lessen hunger & fatigue. Most of the world’s supply of coca is grown & refined into cocaine in Colombia. HIGHEST ABUSE LIABILITY. 45
  • 46. How is it used SNIFFED (15 – 30 min) 46 SMOKED (5-10 min) INJECTED 3min
  • 47. Cocaine Pharmacodynamics Indirect Agonist for DA (high affinity) NE (high affinity) 5-HT (modest affinity) 47 • Mechanism: – Blocks monoamine reuptake
  • 48. Short-term effects Dilated pupils Increased body temperature, Blood pressure & heart rate Insomnia Loss of appetite Increased energy Reduced fatigue Mental clarity Talkativeness 48
  • 49. Long-term effects Paranoia Depression Ulcers in the membranes of the nose Dulled senses of taste & smell Weight loss, poor health & sexual dysfunction Loss of social & financial supports Holes in bony separation between nostrils in nose 49
  • 50. 50
  • 51. COCAINE+ HEROIN Concurrent or substitute use Multiple drug use (nicotine, alcohol, heroin, amphetamines, hallucinogens). Cocaine + heroin => “speed ball” 51
  • 52. PHARMACOTHERAPIES Treatment of withdrawal: Alpha-blockers Chlorpromazine: DA antagonist (also blocks alpha receptors) Haloperidol (antipsychotic – 50x more potent than chlorpromazine). Alprazolam (Xanax - benzodiazepine) for panic attacks. Antidepressants (fluoxetine or desipramine). Diazepam (Valium) for seizures AMANTIDINE for withdrawl effects of cocaine. 52
  • 53. 53  Cocaine is known to have a number of effects during pregnancy.  elevated risk of placental abruption  Due to its vasoconstrictive and hypertensive effects, they are also at risk for haemorrhagic stroke and myocardial infarction.  Cocaine is also teratogenic it can cause birth defects and foetal malformations.  cocaine babies COCAINE IN PREGNANCY
  • 54. METHYLXANTHINES  Only caffeine if used as CNS stimulant PK:  Oral- rapid but irregular absorption  PPB:<50%  Distributed all over the body  Metabolism: in liver by demethylation & oxid.  Metabolites excreted in urine  T1/2: 3-6hrs
  • 55.
  • 56.
  • 57. AE:  Gastric irritation, Nause, Vomiting.  Nervousness, insomnia, agitation  Muscule twitch, rigidity  ↑body temp, delirium, convulsions  Tachy, extra systoles at high doses Uses:  In Analgesic mixture for headache  Migraine  Apnoea in premature infants
  • 58. PSYCHOTOMIMETIC 58  LYSEGIC ACID DIETHYLAMIDE  MESCALINE  PHENCYCLIDINE  CANNABINOIDS  Molecular target- 5-HT2AR – Gq receptor  Hallucinogens
  • 59. LYSERGIC ACID DIETHYLAMIDE  Derived from cereal fungus ergot  Hofmann synthesized & experimented on himself.  Act as agonist at 5HT2 receptors. suppress electrical activity in sertoninergic raphe  Excitation threshold of retina ↓- visual hallucinations, hyper arousal state  Experiences may be bad or good trip. psychedelic effects with 1μg/kg. trips lasting for 6-12 hours. experience flashbacks at any time.
  • 60.
  • 61. Mescaline Mescaline – A hallucinogen obtained from a small spineless cactus Peyote. From earliest recorded time, peyote has been used by natives in northwestern Mexico and the southwestern United States as a part of traditional religious rites. The drug is usually taken orally, without chewing, although it can still be smoked, or even injected. It’s chemical structure is close to that of an amphetamine (stimulant). 61
  • 62. PSILOCYBIN MUSHROOMS How are they taken? Eaten raw Cooked in food Brewed in tea Dried and ingested Street names: Magic mushrooms “Shrooms” How long does a trip last? 5-6 hours 62
  • 63. Psilocybin Mushrooms Effects Nausea Dilated pupils Tightness in the neck • Induce sensory hallucinations • Hear things that are not real Effects caused by shrooms begin about 30 min. after consumption and last nearly 5 hours. During this period, laughing is somewhat uncontrollable and visual hallucinations caused by organic objects are typical. Psilocybin acts by affinity to serotonin 5-HT receptors. 63
  • 64.
  • 65. CANNABINOIDS  Cannabis Sativa (Hemp) Cannabis indicia  GATEWAY DRUG Psychoactive agent = ∆9 Tetrahydocannabinol (THC) Found in all parts of the plant, but concentrated in the sticky resin secreted from the flowing tops of ♀ plants. WORLDS MOST POPULAR DRUG OF ABUSE  The herb was called GANJIKA in Sanskrit 65
  • 66. HASH OIL: It obtained by extracting THC from Hashish or Marijuana in oil.  Clear pale yellow / green to brown black colour.  THC concentration 15-30%. GANJA: Buds and flowering top of female plant. BHANG: Cut and dried large leaves & stem of plants. 6 66
  • 67. 67 MARIJUANA - Dried and crumbled leaves, small stems, flowing tops of the plant - Usually smoked in joints, pipes, bongs, - also called grass, pot,weed,reefer. - THC content varies… SINSEMILLA: pollination prevented (↑ potency) The Gang Bong: The 4 barrel brain blaster!
  • 69. Common Routes- CANNABINOIDS 69  Smoking  Oral ingestion  Cannabis tea  Cannabis+alcohol = green dragon
  • 70. PHARMACOLOGY OF CANNABIS  11- hydroxyl ∆9-THC.(active form)  Typical Joint contains approximately 0.5 – 1g of cannabis - If THC content = 4%... joint with 1g of cannabis contains 40 mg of THC  Burning marijuana results in vaporisation of THC→ absorption into the lungs  Only about 20% of original THC is absorbed: Breathing isn’t optimal – can be increased by breath holding Increased high with 15 s breath hold vs. 7 s 70
  • 71. ACTIONS - CANNABIS 71 DURING SEDATIVE PHASE: IMPAIRED CONCENTRATION LSD LIKE EFFECTS IMPAIRED SHORT TERM MEMORY - DURING STIMULATORY PHASE: EUPHORIA TALKTIVENSS, APPETITE FEELING OF WELL-BEING MOOD TRIPS WILL BE SEEN. PERIPHERAL EFFECTS: TACHYCARDIA BLOODSHOT EYES IOP BRONCHODILATATION AMOTIVATION SYNDROME. RUNNING AMOK CHRONIC POISONING
  • 72. MOA, USES  Two types CB 1& 2 receptors  CB1 in brain CB2 in periphery  Anandamide-endogenous ligand CB1.  Dronabinol, Nabilone- synt.analogues of THC  Use: CB1 Agonists- ↑appetite in AIDSpts.  Dronabinol-antiemetic in cancerchemo.  Rimonabant : CB1 antagonist, used for obesity, dose-20mg OD before Breakfast  Smoking cessation
  • 74. COGNITION ENHANCERS Cognition is "the mental action or process of acquiring knowledge and understanding through thought, experience, and the senses.“ It encompasses processes such as knowledge, attention, memory and working memory, judgment and evaluation, reasoning an d "computation", problem solving and decision making, comprehension and production of language,
  • 75. COGNITION ENHANCERS Indications:  AD, multi infarct dementia  Mild cognitive impairment  learning defects, ADHD in children  CVA, Stroke,TIA  Organic psychosyndromes  Sequale of head injury  ECT, brain surgery
  • 76. MECHANISMS  ↑ global/regional blood flow(CBF)  Direct support of neuronal metabolism  Enhancement of neurotransmission  Improvement of discrete cerebral functions (memory)
  • 77. ALZHEIMERS DISEASE  Main pathological features:  Amyloid plaque  Neurofibrillary tangles  Marked ↓ in choline acetyltransferase & loss of cholinergic neurons in brain.
  • 78. CHOLINERGIC ACTIVATORS  ACEs that cross BBB are preferred. Tacrine:  Longer acting, reversible ACE  Palliative for mild to moderate AD  Orally active  Improves memory, cognition, well being  Facilitates Ach release  AE: hepatotoxicity
  • 79.
  • 80. DONEPEZIL, RIVASTIGMINE & GALANTAMINE  Newer reversible Anti cholinesterase  Better penetration in to CNS(lipid soluble)  Better tolerated & less toxic than tacrine  Clinical results modest & temporary  Donepezil: 5mg OD orally evening ↑ max 10mg after 4 wks  Rivastigmine:1.5 mg orally BD ↑ to 3mg BD after 2 wks upto max 6mg/BD.  Galantamine:4mg BD orally ↑to 8mg BD after 2 wks
  • 81.  Transdermal Rivastigmine patch –applied every 24hrs  SE:diarrhoe, N, V, ↑urination Acetyl-L-carnitine:  Structural analogue of Ach  ↓ signs & symptoms of dementia in AD  ↑ cholinergic transmission  Also have antioxidant properties, slows progression ofAD
  • 82. MEMANTINE  Excitotoxicity due to enhanced Glutamate transmission via NMDA recp.  Dose:5mg OD slowly ↑ to 10-20mg/day  Non-comp. antagonist of NMDA recp.  Better tolerated, less toxic. Miscellaneous :  Nootropics- piracetam, aniracetam  High doses of vit E(1000 IU B.D)  Antioxidants-vit C, A, Zn, Se, bioflavonoids or spirulina ↓ progression even in middle stage AD.
  • 83.
  • 84. 84 PIRACETAM MOA:- ↑ ACh activity in the brain ↑ glutamate activity via AMPA and NMDA receptors ~ improve membrane permeability of neurons→ enhances overall neuronal function. USE :- Cognitive impairement & Dementia in elderly, ADHD. DOSE:- 0.8-1 gm TDS, Oral 1-3 gm, i.m, 6th hrly.
  • 85. 85 Natural Nootropics:- Bacopa monnieri (Brahmi): • Enhancement of PK activity, protein synthesis in hippocampus • Natural antioxidant & DNA damage preventing agent •Anti stress property • It enhances memory and intellect.
  • 86. 86ASHWAGANDHA:  Indian GINSENG  Anti oxidant properties  Neuronal regeneration : Which helps in Neuro degenerative disorders.  Extract inhibits AchE enzyme.
  • 87. 87 Ginkgo biloba:  Neuro protective effects Antioxidant, Anti apoptotic, Anti amyloidogenic properties Used in Alzhiemer’s disease , other cognitive disorders. Panax Ginseng (king herb):  Chinese traditional medicine Antioxidant property Release of neurotransmitters in the brain